Efficacy and Safety of Fimasartan Alone or Combined With HCTZ in Mexican Patients With Essential Hypertension

PHASE3CompletedINTERVENTIONAL
Enrollment

272

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

February 28, 2014

Study Completion Date

February 28, 2014

Conditions
Hypertension, Essential
Interventions
DRUG

Fimasartan

Fimasartan tablets

DRUG

Fimasartan; Hydrochlorothiazide

Fimasartan plus hydrochlorothiazide fixed dose combination tablets

Trial Locations (13)

22010

Centro Médico Exel, Tijuana

44100

Hospital Civil de Guadalajara Fray Antonio Alcalde, Guadalajara

44140

Unidad de Investigación Clínica Cardiometabólica de Occidente, Guadalajara

44340

Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara

44600

Icle S.C., Guadalajara

Instituto Jalisciense de Investigación en Diabetes y Obesidad S. C., Guadalajara

44860

Núcleo Médico La Paz, Guadalajara

45157

Hospital Dr. Ángel Leaño, Zapopan

64060

Cardiolink Clintrials, Monterrey

64620

Centro de Estudios Clínicos y Especialidades Médicas, Monterrey

78240

Hospital Dr. Ignacio Morones Prieto, San Luis Potosí City

06090

Hospital de Jesús IAP, México

07330

Hospital General de Ticomán, México

All Listed Sponsors
lead

Stendhal Americas, S.A.

INDUSTRY

NCT02466490 - Efficacy and Safety of Fimasartan Alone or Combined With HCTZ in Mexican Patients With Essential Hypertension | Biotech Hunter | Biotech Hunter